Clinical trials in Heilbronn – page 9

Innovative trials focusing on Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia, testing novel drug combinations to improve patient outcomes. Research includes evaluating treatments for both adult and pediatric patients with various forms of leukemia.

• Novel drug combinations for AML treatment
• Targeted therapies for specific genetic mutations
• Pediatric leukemia protocols

Studies aim to enhance survival rates and develop more effective treatment strategies for blood cancer patients.

Comprehensive studies addressing different types of breast cancer, particularly focusing on triple-negative breast cancer and HER2-positive disease. Research includes both early-stage and metastatic disease treatments.

• Advanced therapeutic approaches for TNBC
• Adjuvant therapy optimization
• Personalized treatment strategies

Trials evaluate novel drug combinations and targeted therapies to improve patient outcomes.

Research focusing on various digestive system cancers, including gastric cancer, colorectal cancer, and pancreatic cancer. Studies evaluate both early-stage and advanced disease treatments.

• Advanced gastric cancer therapies
• Preoperative treatment strategies
• Novel combination approaches

Investigations aim to improve surgical outcomes and treatment effectiveness for GI cancers.